Softwr

Healthcare · head to head

Lunit vs Visage Imaging

Lunit logo

Lunit

Healthcare

FDA cleared and CE marked AI for mammography, tomosynthesis and chest radiography

From
On request
Rated
-
Full reviewWebsite
Visage Imaging logo

Visage Imaging

Healthcare

Server-side streaming PACS built for radiologists reading very large studies over thin connections

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Lunit the regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.; Visage Imaging pricing is per exam against a minimum annual volume, so an organisation whose imaging activity is flat pays a floor while a growing one sees the software line rise every year rather than amortise.
  • They diverge on capability: Lunit covers Lunit INSIGHT MMG, Visage Imaging covers Server-side rendering.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Lunit and Visage Imaging actually diverge.

Attributes where Lunit and Visage Imaging differ
AttributeLunitVisage Imaging
PlatformsWebWindows, macOS, Web, iOS, Cloud

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Lunit

  • Lunit INSIGHT MMG
  • Lunit INSIGHT DBT
  • Lunit INSIGHT CXR
  • Volpara density assessment
  • Volpara RiskPathways
  • Volpara dose tracking
  • PACS and mammography workstation integration

Only in Visage Imaging

  • Server-side rendering
  • One Viewer
  • Native multi-dimensional tools
  • Digital breast tomosynthesis reading
  • Open archive
  • Cloud PACS operations
  • AI accelerator
  • On the fly patient jacket

What people use each for

The jobs each tool is most often brought in to do.

Lunit

  • A national breast screening programme evaluating AI as a second reader to reduce double reading workload where two human readers are currently mandatednot Visage Imaging
  • A breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on DBT specificallynot Visage Imaging
  • An American breast imaging centre needing automated volumetric density assessment to meet patient density notification requirements, which is what Volpara is bought fornot Visage Imaging
  • A tuberculosis or lung screening programme in a high volume, radiologist scarce setting using chest radiography triage to prioritise filmsnot Visage Imaging

Visage Imaging

  • An academic health system whose radiologists read from home and cannot tolerate a thousand slice CT taking minutes to opennot Lunit
  • A breast imaging service moving to tomosynthesis where study sizes have made the existing PACS unusable at volumenot Lunit
  • A teleradiology group covering many client sites that needs one viewer rather than a client-specific workstation per contractnot Lunit
  • A health system mid migration that needs priors from three legacy archives assembled into one patient jacket before the data move finishesnot Lunit

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Lunit

  • The regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.
  • Detection AI changes recall rates in screening, and the downstream cost of additional diagnostic workup lands on the programme rather than on the software budget, which is the cost most screening business cases omit.
  • Performance is sensitive to the mammography vendor and acquisition protocol, so published results from a Hologic estate do not transfer to a GE or Siemens estate without local validation the buyer must fund.
  • MMG, DBT and CXR are licensed separately and Volpara modules are separate again, so a breast centre wanting detection, density and risk pathways is assembling four line items rather than buying one product.
  • Using AI as a replacement for one of two human readers is a workforce and liability decision that regulators and professional bodies treat differently in each country, so the saving that justifies the purchase may not be permitted where you operate.

Visage Imaging

  • Pricing is per exam against a minimum annual volume, so an organisation whose imaging activity is flat pays a floor while a growing one sees the software line rise every year rather than amortise.
  • Module breadth outside radiology is narrower than at Sectra or the large modality vendors, so a group planning to digitise pathology on the same platform will not find it here.
  • Server-side rendering shifts the cost to central infrastructure, so the saving on radiologist workstations is partly offset by what you spend on servers or cloud compute.
  • Pro Medicus concentrates on very large contracts, and smaller imaging groups report long sales cycles and little appetite from the vendor for deals below a certain volume.
  • Diagnostic AI is third party, surfaced through the accelerator framework rather than developed in house, so algorithm licensing, validation and monitoring remain the buyer problem.

Pricing, plan by plan

Lunit

On request
  • Lunit INSIGHT$undefined/year
    • Priced per study or per annual examination volume by product
    • MMG, DBT and CXR licensed separately
    • Volpara density and RiskPathways modules quoted separately

Visage Imaging

On request
  • Visage 7 enterprise contract$undefined/year
    • Transaction pricing per exam with a minimum annual volume commitment
    • Seven to ten year terms typical for health system contracts
    • Contract totals for major deals are disclosed by Pro Medicus to the ASX

Which should you pick?

Choose Lunit if

  • You need lunit insight mmg.
  • You also want lunit insight dbt.
Lunit review

Choose Visage Imaging if

  • You need server-side rendering.
  • You work on Windows, macOS, Web, iOS, Cloud.
  • You also want one viewer.
Visage Imaging review

Questions people ask

Is Lunit or Visage Imaging better?
Neither clearly leads. Lunit starts at On request and Visage Imaging at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Lunit or Visage Imaging?
Lunit starts at On request and Visage Imaging at On request.
Does Lunit or Visage Imaging run on more platforms?
Lunit runs on Web. Visage Imaging runs on Windows, macOS, Web, iOS, Cloud.
What is Lunit best used for?
Lunit is most often used for a national breast screening programme evaluating ai as a second reader to reduce double reading workload where two human readers are currently mandated, a breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on dbt specifically, an american breast imaging centre needing automated volumetric density assessment to meet patient density notification requirements, which is what volpara is bought for, a tuberculosis or lung screening programme in a high volume, radiologist scarce setting using chest radiography triage to prioritise films. Of those, a national breast screening programme evaluating ai as a second reader to reduce double reading workload where two human readers are currently mandated and a breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on dbt specifically are not what Visage Imaging is typically brought in for.
What can Lunit do that Visage Imaging cannot?
Lunit covers Lunit INSIGHT MMG, Lunit INSIGHT DBT, Lunit INSIGHT CXR, Volpara density assessment. Visage Imaging covers Server-side rendering, One Viewer, Native multi-dimensional tools, Digital breast tomosynthesis reading.

Answered from the vendors’ own pages

Lunit: Is Lunit FDA cleared?

Yes for specific products. INSIGHT MMG, INSIGHT DBT and INSIGHT CXR Triage hold FDA 510(k) clearances. INSIGHT Risk, the five year risk prediction model, has been filed but was not cleared at the time of writing.

Visage Imaging: Who owns Visage Imaging?

Pro Medicus Limited, listed on the Australian Securities Exchange. That listing means major contract values and terms are publicly announced.

Lunit: Can Lunit replace a second human reader in screening?

That depends entirely on your jurisdiction and professional body guidance, not on the software. The CE mark permits clinical use; it does not authorise a workforce model.

Visage Imaging: How is Visage priced?

Per exam, against a minimum annual volume, on multi-year terms. Because Pro Medicus discloses large contract totals and durations to the market, buyers can estimate a per exam rate before entering negotiation.

Lunit: What did the Volpara acquisition add?

Volumetric breast density measurement, dose tracking and RiskPathways high risk programme management, which are the things American breast centres buy for density notification compliance rather than for detection.

Visage Imaging: Is Visage 7 FDA cleared for diagnostic interpretation?

Yes, Visage 7 holds 510(k) clearance for diagnostic viewing including mammography and tomosynthesis on validated displays. Confirm the exact cleared modality list for your intended use.

Lunit: Is pricing published?

No. It is quoted per study or per annual volume, by product, with on premises and cloud priced differently.

Visage Imaging: Does it work as a full cloud PACS?

Yes, Visage 7 runs complete PACS operations in the cloud rather than cloud viewing over an on-premise archive.

Share

Related pages

More on Lunit

More on Visage Imaging

Keep looking

Other head to heads